2BBBullish & Bearish
Health Care

C4 Therapeutics, Inc. (CCCC) Stock Score & Signals

C4 Therapeutics, Inc. (CCCC) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 49 out of 100.

2BB score and signals

C4 Therapeutics, Inc.’s current 2BB score is 49 out of 100, built from the signal categories below.

SignalScoreReading
Activity66High
Momentum64Improving
Financial strength17Very Weak
Quality100Very Strong
Risk45Moderate

Company facts

HeadquartersWatertown, Massachusetts, United States
Founded2015
Employees104
52-week range$1.69 – $5.17

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-02-24—-0.2605—$3.83M
2026-11-04—-0.2279—$4.87M
2026-08-05—-0.2309—$4.08M
2026-05-12-0.2-0.3794$6.15M$3.40M